Technology Insight: Modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization

Luca Persani, Davide Calebiro, Marco Bonomi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The formation of supramolecular structures (dimers or oligomers) is emerging as an important aspect of G-protein-coupled receptor (GPCR) biology. In some cases, GPCR oligomerization is a prerequisite for membrane targeting or function; in others, the relevance of the phenomenon is presently unknown. Although supramolecular structures of GPCRs were initially documented by classical biochemical techniques such as coimmunoprecipitation, many recent advances in the field of GPCR oligomerization have been prompted by the introduction of two new biophysical assays based on Förster's resonance energy transfer-fluorescence resonance energy transfer and bioluminescence resonance energy transfer. These modern techniques allow the study of protein-protein interaction in intact cells, and can be used to monitor monomer association and dissociation in vivo. Recently, oligomerization has also been reported in the case of the TSH receptor (TSHR). This review will focus on the previously unsuspected implications that oligomerization has in TSHR physiology and pathology. It is now clear that TSHR oligomerization is constitutive, occurs early during post-translational processing, and may be involved in membrane targeting and activation by the hormone or by stimulating antibodies. Oligomerization between inactive mutants and wild-type TSHR provides a molecular explanation for the dominant forms of TSH resistance.

Original languageEnglish
Pages (from-to)180-190
Number of pages11
JournalNature Clinical Practice Endocrinology and Metabolism
Volume3
Issue number2
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Thyrotropin Receptors
G-Protein-Coupled Receptors
Technology
Energy Transfer
Proteins
Fluorescence Resonance Energy Transfer
Membranes
Hormones
Pathology
Antibodies

Keywords

  • Bioluminescence resonance energy transfer
  • Fluorescence resonance energy transfer
  • G-protein-coupled receptor oligomerization
  • TSH receptor
  • TSH resistance

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{431175ff067e4233853ec2124c48080a,
title = "Technology Insight: Modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization",
abstract = "The formation of supramolecular structures (dimers or oligomers) is emerging as an important aspect of G-protein-coupled receptor (GPCR) biology. In some cases, GPCR oligomerization is a prerequisite for membrane targeting or function; in others, the relevance of the phenomenon is presently unknown. Although supramolecular structures of GPCRs were initially documented by classical biochemical techniques such as coimmunoprecipitation, many recent advances in the field of GPCR oligomerization have been prompted by the introduction of two new biophysical assays based on F{\"o}rster's resonance energy transfer-fluorescence resonance energy transfer and bioluminescence resonance energy transfer. These modern techniques allow the study of protein-protein interaction in intact cells, and can be used to monitor monomer association and dissociation in vivo. Recently, oligomerization has also been reported in the case of the TSH receptor (TSHR). This review will focus on the previously unsuspected implications that oligomerization has in TSHR physiology and pathology. It is now clear that TSHR oligomerization is constitutive, occurs early during post-translational processing, and may be involved in membrane targeting and activation by the hormone or by stimulating antibodies. Oligomerization between inactive mutants and wild-type TSHR provides a molecular explanation for the dominant forms of TSH resistance.",
keywords = "Bioluminescence resonance energy transfer, Fluorescence resonance energy transfer, G-protein-coupled receptor oligomerization, TSH receptor, TSH resistance",
author = "Luca Persani and Davide Calebiro and Marco Bonomi",
year = "2007",
month = "2",
doi = "10.1038/ncpendmet0401",
language = "English",
volume = "3",
pages = "180--190",
journal = "Nature Clinical Practice Endocrinology and Metabolism",
issn = "1745-8366",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Technology Insight

T2 - Modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization

AU - Persani, Luca

AU - Calebiro, Davide

AU - Bonomi, Marco

PY - 2007/2

Y1 - 2007/2

N2 - The formation of supramolecular structures (dimers or oligomers) is emerging as an important aspect of G-protein-coupled receptor (GPCR) biology. In some cases, GPCR oligomerization is a prerequisite for membrane targeting or function; in others, the relevance of the phenomenon is presently unknown. Although supramolecular structures of GPCRs were initially documented by classical biochemical techniques such as coimmunoprecipitation, many recent advances in the field of GPCR oligomerization have been prompted by the introduction of two new biophysical assays based on Förster's resonance energy transfer-fluorescence resonance energy transfer and bioluminescence resonance energy transfer. These modern techniques allow the study of protein-protein interaction in intact cells, and can be used to monitor monomer association and dissociation in vivo. Recently, oligomerization has also been reported in the case of the TSH receptor (TSHR). This review will focus on the previously unsuspected implications that oligomerization has in TSHR physiology and pathology. It is now clear that TSHR oligomerization is constitutive, occurs early during post-translational processing, and may be involved in membrane targeting and activation by the hormone or by stimulating antibodies. Oligomerization between inactive mutants and wild-type TSHR provides a molecular explanation for the dominant forms of TSH resistance.

AB - The formation of supramolecular structures (dimers or oligomers) is emerging as an important aspect of G-protein-coupled receptor (GPCR) biology. In some cases, GPCR oligomerization is a prerequisite for membrane targeting or function; in others, the relevance of the phenomenon is presently unknown. Although supramolecular structures of GPCRs were initially documented by classical biochemical techniques such as coimmunoprecipitation, many recent advances in the field of GPCR oligomerization have been prompted by the introduction of two new biophysical assays based on Förster's resonance energy transfer-fluorescence resonance energy transfer and bioluminescence resonance energy transfer. These modern techniques allow the study of protein-protein interaction in intact cells, and can be used to monitor monomer association and dissociation in vivo. Recently, oligomerization has also been reported in the case of the TSH receptor (TSHR). This review will focus on the previously unsuspected implications that oligomerization has in TSHR physiology and pathology. It is now clear that TSHR oligomerization is constitutive, occurs early during post-translational processing, and may be involved in membrane targeting and activation by the hormone or by stimulating antibodies. Oligomerization between inactive mutants and wild-type TSHR provides a molecular explanation for the dominant forms of TSH resistance.

KW - Bioluminescence resonance energy transfer

KW - Fluorescence resonance energy transfer

KW - G-protein-coupled receptor oligomerization

KW - TSH receptor

KW - TSH resistance

UR - http://www.scopus.com/inward/record.url?scp=33846440512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846440512&partnerID=8YFLogxK

U2 - 10.1038/ncpendmet0401

DO - 10.1038/ncpendmet0401

M3 - Article

C2 - 17237844

AN - SCOPUS:33846440512

VL - 3

SP - 180

EP - 190

JO - Nature Clinical Practice Endocrinology and Metabolism

JF - Nature Clinical Practice Endocrinology and Metabolism

SN - 1745-8366

IS - 2

ER -